Search results for " fibrillation"

showing 10 items of 478 documents

Abstract WP200: Development and Validation of a Score to Detect Paroxysmal Atrial Fibrillation During Long-term Holter-monitoring After Acute Ischemi…

2018

Introduction: Atrial fibrillation remains one of the most common causes of ischemic stroke. The diagnosis of paroxysmal atrial fibrillation (pAF) frequently escapes routine diagnostic due to its intermittent and asymptomatic occurrence. Currently prolonged monitoring times (72h) are recommended, but did not find their way into everyday practice. Therefore an individual patient selection for prolonged ECG-monitoring might increase the diagnostic yield of pAF in a resource-saving and cost-effective manner. Methods: We used individual patient data from three prospective studies (n total =1556) which performed a prolonged Holter ECG-monitoring (at least 72 h) and centralized data evaluation af…

Advanced and Specialized Nursingmedicine.medical_specialtymedicine.diagnostic_testbusiness.industryParoxysmal atrial fibrillationAtrial fibrillation030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicineInternal medicineIschemic strokeCardiologymedicineNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessHolter monitoringStrokeElectrocardiographyAcute ischemic stroke030217 neurology & neurosurgeryStroke
researchProduct

Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Surve…

2006

Objectives: This study sought to investigate gender-related differences in patients with atrial fibrillation (AF) in Europe. Background: Gender-related differences may play a significant role in AF. Methods: We analyzed the data of 5,333 patients (42% female) enrolled in the Euro Heart Survey on Atrial Fibrillation. Results: Compared with men, the women were older, had a lower quality of life (QoL), had more comorbidities, more often had heart failure (HF) with preserved left ventricular systolic function (18% vs. 7%, p < 0.001), and less often had HF with systolic dysfunction (17% vs. 26%, p < 0.001). Among patients with typical AF symptoms (56% of women, 49% of men), there was no ge…

Aged 80 and overHeart FailureMaleHealth StatusHealth SurveyMiddle AgedHealth SurveysFollow-Up StudieHealth StatuEuropeStrokeSex FactorsTreatment OutcomeAtrial FibrillationQuality of LifeHumansFemaleHumanAgedFollow-Up StudiesJournal of the American College of Cardiology
researchProduct

Obesity and new-onset atrial fibrillation in acute myocardial infarction: a gender specific risk factor

2014

Aged 80 and overMaleSex Characteristicsmedicine.medical_specialtybusiness.industryMyocardial InfarctionSpecific riskAtrial fibrillationMiddle Agedmedicine.diseaseObesityNew onset atrial fibrillationRisk FactorsInternal medicineAtrial FibrillationmedicineCardiologyHumansFemaleObesityMyocardial infarctionCardiology and Cardiovascular MedicinebusinessAgedInternational Journal of Cardiology
researchProduct

Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction

2015

International audience; Background Atrial fibrillation (AF), whether silent or symptomatic, is a frequent and severe complication of acute myocardial infarction (AMI). Asymmetric dimethylarginine (ADMA), an endogenous eNOS inhibitor, is a risk factor for endothelial dysfunction. We addressed the relationship between ADMA plasma levels and AF occurrence in AMI.Methods 273 patients hospitalized for AMI were included. Continuous electrocardiographic monitoring (CEM) !48 hours was recorded and ADMA was measured by High Performance Liquid Chromatography on admission blood sample.Results The incidence of silent and symptomatic AF was 39(14%) and 29 (11%), respectively. AF patients were markedly o…

Aged 80 and overMalelcsh:RMyocardial Infarctionlcsh:MedicineMiddle AgedArginineRisk Assessment[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemElectrocardiographyOxidative StressLogistic Models[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemRisk FactorsAtrial FibrillationMultivariate AnalysisHumansFemalelcsh:QEndotheliumlcsh:ScienceBiomarkersChromatography High Pressure LiquidResearch ArticleAged
researchProduct

Urea Cycle Metabolites and Atrial Fibrillation or Heart Failure Risk: Two Case-Control Studies in the PREDIMED Trial

2021

OBJECTIVES: To prospectively analyze the associations between urea cycle metabolites and incident atrial fibrillation (AF) or heart failure (HF), and to evaluate the effect of a Mediterranean diet (MD) intervention on such associations. METHODS: We designed two nested case-control studies within the PREDIMED trial, a randomized controlled trial aimed to evaluate the effect of two MD interventions, supplemented with either extra virgin olive oil (EVOO) or nuts, on cardiovascular disease (CVD). Fasting blood samples were collected at baseline and urea cycle metabolites (arginine, citrulline, and ornithine) and methylarginines (asymmetric dimethylarginine/symmetric dimethylarginine ratio (ADMA…

Aging and Chronic DiseaseNutrition and DieteticsArginineMediterranean dietDiet therapybusiness.industryMedicine (miscellaneous)Atrial fibrillationPharmacologyOrnithinemedicine.diseasechemistry.chemical_compoundchemistryHeart failureUrea cyclemedicineCitrullinebusinessFood ScienceCurrent Developments in Nutrition
researchProduct

Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study

2016

Background: Atrial fibrillation (AF) is associated with a substantial risk of thromboembolism and mortality, significantly reduced by oral anticoagulation. Adherence to guidelines may lower the risks for both all cause and cardiovascular (CV) deaths. Methods: Our objective was to evaluate if antithrombotic prophylaxis according to the 2012 European Society of Cardiology (ESC) guidelines is associated to a lower rate of adverse outcomes. Data were obtained from REPOSI; a prospective observational study enrolling inpatients aged ≥65 years. Patients enrolled in 2012 and 2014 discharged with an AF diagnosis were analysed. Results: Among 2535 patients, 558 (22.0 %) were discharged with a diagnos…

Antithrombotic therapy; Atrial fibrillation; Elderly; Guidelines; Outcomes; Cardiology and Cardiovascular MedicineMaleRegistrieTime Factorsantithrombotic therapy; atrial fibrillation; elderly; guidelines; outcomesAtrial fibrillation (AF)Practice PatternsKaplan-Meier Estimate030204 cardiovascular system & hematologyGuidelineoutcomesCoronary artery disease0302 clinical medicineElderlyRisk FactorsAtrial FibrillationAntithrombotic80 and overAge Factor030212 general & internal medicineRegistriesguidelinesAntithrombotic therapy Atrial fibrillation Elderly Guidelines OutcomesPractice Patterns Physicians'OutcomeAged 80 and overFibrinolytic AgentAge FactorsAtrial fibrillationGeneral MedicineTreatment OutcomeItalyAtrial fibrillation (AF) thromboembolism antithrombotic prophylaxisPractice Guidelines as TopicCardiologyFemaleGuideline AdherenceCardiology and Cardiovascular MedicineHumanAntithrombotic therapy; Atrial fibrillation; Elderly; Guidelines; Outcomes; Age Factors; Aged; Aged 80 and over; Atrial Fibrillation; Chi-Square Distribution; Female; Fibrinolytic Agents; Guideline Adherence; Humans; Italy; Kaplan-Meier Estimate; Logistic Models; Male; Practice Patterns Physicians'; Proportional Hazards Models; Registries; Risk Assessment; Risk Factors; Thromboembolism; Time Factors; Treatment Outcome; Practice Guidelines as Topic; Cardiology and Cardiovascular Medicinemedicine.medical_specialtyLogistic ModelTime FactorSocio-culturaleLower riskRisk Assessment03 medical and health sciencesFibrinolytic AgentsInternal medicineThromboembolismmedicineHumansProportional Hazards ModelsAgedAntithrombotic therapyPhysicians'Chi-Square Distributionbusiness.industryProportional hazards modelRisk FactorSettore MED/09 - MEDICINA INTERNAGuidelinethromboembolismmedicine.diseaseAtrial fibrillationLogistic ModelsProportional Hazards Modelantithrombotic prophylaxisbusinessChi-squared distributionFibrinolytic agent
researchProduct

Incidence, Predictive Factors, and Prognostic Impact of Silent Atrial Fibrillation After Transcatheter Aortic Valve Implantation.

2018

New onset atrial fibrillation post-transcatheter aortic valve implantation (TAVI) is common and is associated with adverse outcomes. However, silent atrial fibrillation (AF) is poorly documented in the context. This study sought to evaluate the incidence, predictive factors, and prognostic value of Silent AF post-TAVI. All the consecutive patients with TAVI were prospectively analyzed by continuous electrocardiogram monitoring≥48 hours after implantation. Silent AF was defined as asymptomatic episodes lasting at least 30 seconds. The population was divided into 3 groups: history of AF, no-AF, and silent AF. Among the 206 patients implanted with TAVI, 19 (16.1%) developed silent AF. Compared…

Aortic valveMalemedicine.medical_specialtyTime FactorsPopulationContext (language use)030204 cardiovascular system & hematologyAsymptomaticTranscatheter Aortic Valve Replacement03 medical and health sciencesElectrocardiography0302 clinical medicinePostoperative ComplicationsRisk FactorsInternal medicineAtrial FibrillationmedicineHumans030212 general & internal medicineProspective StudiesRegistriesProspective cohort studyeducationAged 80 and overeducation.field_of_studymedicine.diagnostic_testbusiness.industryIncidenceAtrial fibrillationAortic Valve Stenosismedicine.diseasePrognosismedicine.anatomical_structureAortic valve stenosisAortic ValveCardiologyFemaleFrancemedicine.symptomCardiology and Cardiovascular MedicinebusinessElectrocardiographyFollow-Up StudiesThe American journal of cardiology
researchProduct

Chronic atrial fibrillation in presence of aortic stenosis in a patient with polysplenia syndrome.

2013

We report a rare case of “situs viscerum ambiguous” with polysplenia syndrome, in a 69 year old female patient with aortic stenosis and chronic atrial fibrillation. The presenting symptom was dyspnoea on moderate exertion and an ECG showed supra ventricular arrhythmia. Patients trans-thoracic echocardiogram revealed a dilated left atrium, reduced ejection fraction, mild tricuspid regurgitation, moderate-severe pulmonary hypertension and severe aortic stenosis. The patient was successfully treated with a replacement of her aortic valve and ascending aorta.

Aortic valvemedicine.medical_specialtyPolysplenia syndromeRegurgitation (circulation)Heterotaxy SyndromePolysplenia Aortic Stenosis Atrial Fibrillationmedicine.arteryInternal medicineAscending aortaAtrial FibrillationMedicineChronic atrial fibrillationHumanscardiovascular diseasesAortaAgedHeart Valve Prosthesis ImplantationEjection fractionbusiness.industryGeneral MedicineAortic Valve Stenosismedicine.diseasePulmonary hypertensionSettore MED/11 - Malattie Dell'Apparato CardiovascolareStenosismedicine.anatomical_structureTreatment OutcomeChronic Diseasecardiovascular systemCardiologyFemalebusinessActa clinica Belgica
researchProduct

Morphology-based measurement of activation time in human atrial fibrillation

2003

The measurement of the activation time is crucial to allow the correct automatic analysis and classification of intracardiac electrograms recorded in the human atria during atrial fibrillation (AF). This study proposes a method which accounts for the morphology of bipolar signals. After ventricular artifact removal and activation wave recognition, the fiducial point of the activation wave was set at its local barycentre (LB). The method was tested on a set of 30 AF bipolar recordings of increasing complexity class; its performance was compared with that of the traditional methods of maximum peak (MP) or maximum slope (MS) estimation, taking the manual measurements performed by an expert car…

Artifact (error)medicine.medical_specialtyMaximum slopemedicine.diagnostic_testComputer scienceAtrial fibrillationMathematical morphologymedicine.diseaseLow complexityInternal medicineSettore ING-INF/06 - Bioingegneria Elettronica E InformaticamedicineCardiologyFiducial markerCardiology and Cardiovascular MedicineElectrocardiographyIntracardiac ElectrogramSoftwareBiomedical engineering
researchProduct

Ventricular fibrillation detection from ECG surface electrodes using different filtering techniques, window length and artificial neural networks

2017

Medical personnel face many difficulties when diagnosing ventricular fibrillation (VF). Its correct diagnosis allows to decide the right medical treatment and, therefore, it is essential to tell it apart adequately from ventricular tachycardia (VT) and other arrhythmias. If the required therapy is not appropriate, the personnel could cause serious injuries or even induce VF. In this work, a diagnosis automatic system for the detection of VF through feature extraction was developed. To verify the validity of this method, an Artificial Neural Network (ANN) classifier was used. The ECG signals used were obtained from the MIT-BIH Malignant Ventricular Arrhythmia Database and AHA (2000 series) d…

Artificial neural networkMedical treatmentmedicine.diagnostic_testComputer sciencebusiness.industryFeature extractionPattern recognitionmedicine.diseaseVentricular tachycardiaVentricular fibrillationmedicineArtificial intelligenceEcg signalbusinessElectrocardiographyClassifier (UML)2017 International Conference on Emerging Trends in Computing and Communication Technologies (ICETCCT)
researchProduct